Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

NCT00062504 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Anaplastic Mixed Oligoastrocytoma

Interventions

DRUG: Talampanel

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]